{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:25:39Z","timestamp":1789079139510,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T00:00:00Z","timestamp":1428019200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12951-015-0088-2","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T17:16:14Z","timestamp":1427994974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells"],"prefix":"10.1186","volume":"13","author":[{"given":"Sara","family":"Maiolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapina","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pagliara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,3]]},"reference":[{"key":"88_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1741-7015-8-83","volume":"8","author":"KK Jain","year":"2010","unstructured":"Jain KK. Advances in the field of nanooncology. BMC Med. 2010;8:83.","journal-title":"BMC Med"},{"key":"88_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7:653\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"88_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","volume":"63","author":"AZ Wang","year":"2012","unstructured":"Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185\u201398.","journal-title":"Annu Rev Med"},{"key":"88_CR4","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1021\/mp200394t","volume":"8","author":"R Duncan","year":"2011","unstructured":"Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm. 2011;8:2101\u201341.","journal-title":"Mol Pharm"},{"key":"88_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrc3180","volume":"12","author":"A Schroeder","year":"2012","unstructured":"Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer. 2012;12:39\u201350.","journal-title":"Nat Rev Cancer"},{"key":"88_CR6","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","volume":"65","author":"JL Markman","year":"2013","unstructured":"Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev. 2013;65:1866\u201379.","journal-title":"Adv Drug Deliv Rev"},{"key":"88_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1517\/17425247.2012.665365","volume":"9","author":"S Palakurthi","year":"2012","unstructured":"Palakurthi S, Yellepeddi VK, Vangara KK. Recent trends in cancer drug resistance reversal strategies using nanoparticles. Expert Opin Drug Deliv. 2012;9:287\u2013301.","journal-title":"Expert Opin Drug Deliv"},{"key":"88_CR8","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.addr.2013.07.012","volume":"65","author":"AK Iyer","year":"2013","unstructured":"Iyer AK, Singh A, Ganta S, Amiji MM. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv Drug Deliv Rev. 2013;65:1784\u2013802.","journal-title":"Adv Drug Deliv Rev"},{"key":"88_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.addr.2012.04.010","volume":"65","author":"P Couvreur","year":"2013","unstructured":"Couvreur P. Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev. 2013;65:21\u20133.","journal-title":"Adv Drug Deliv Rev"},{"key":"88_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1039\/C3NR05444F","volume":"6","author":"CM Hu","year":"2014","unstructured":"Hu CM, Fang RH, Luk BT, Zhang L. Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale. 2014;6:65\u201375.","journal-title":"Nanoscale"},{"key":"88_CR11","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1039\/c2cs15344k","volume":"41","author":"N Kamaly","year":"2012","unstructured":"Kamaly N, Xiao ZY, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;41:2971\u20133010.","journal-title":"Chem Soc Rev"},{"key":"88_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM. Coco R+, Le Breton A, Pr\u2009+\u2009\u00aeat V+: PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505\u201322.","journal-title":"J Control Release"},{"key":"88_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.addr.2012.09.008","volume":"64","author":"R Gref","year":"2012","unstructured":"Gref R, Domb A, Quellec P, Blunk T, Muller RH, Verbavatz JM, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev. 2012;64:316\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"88_CR14","doi-asserted-by":"publisher","first-page":"9343","DOI":"10.1016\/j.biomaterials.2014.07.043","volume":"35","author":"A Ediriwickrema","year":"2014","unstructured":"Ediriwickrema A, Zhou J, Deng Y, Saltzman WM. Multi-layered nanoparticles for combination gene and drug delivery to tumors. Biomaterials. 2014;35:9343\u201354.","journal-title":"Biomaterials"},{"key":"88_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/nn700256c","volume":"2","author":"T Xia","year":"2008","unstructured":"Xia T, Kovochich M, Liong M, Zink JI, Nel AE. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano. 2008;2:85\u201396.","journal-title":"ACS Nano"},{"key":"88_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/nl0722929","volume":"8","author":"PR Leroueil","year":"2008","unstructured":"Leroueil PR, Berry SA, Duthie K, Han G, Rotello VM, McNerny DQ, et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett. 2008;8:420\u20134.","journal-title":"Nano Lett"},{"key":"88_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.biomaterials.2012.09.062","volume":"34","author":"Z Huang","year":"2013","unstructured":"Huang Z, Yang Y, Jiang Y, Shao J, Sun X, Chen J, et al. Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers. Biomaterials. 2013;34:746\u201355.","journal-title":"Biomaterials"},{"key":"88_CR18","first-page":"2231","volume":"119","author":"JR Cubillos-Ruiz","year":"2009","unstructured":"Cubillos-Ruiz JR, Engle X, Scarlett UK, Martinez D, Barber A, Elgueta R, et al. Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J Clin Invest. 2009;119:2231\u201344.","journal-title":"J Clin Invest"},{"key":"88_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10439-012-0630-4","volume":"41","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos T, Soteriou K, Fukumura D, Jain RK. Cationic nanoparticles have superior transvascular flux into solid tumors: Insights from a mathematical model. Ann Biomed Eng. 2013;41:68\u201377.","journal-title":"Ann Biomed Eng"},{"key":"88_CR20","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1016\/j.biomaterials.2013.06.058","volume":"34","author":"H Yim","year":"2013","unstructured":"Yim H, Park SJ, Bae YH, Na K. Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours. Biomaterials. 2013;34:7674\u201382.","journal-title":"Biomaterials"},{"key":"88_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","volume":"114","author":"H Lv","year":"2006","unstructured":"Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006;114:100\u20139.","journal-title":"J Control Release"},{"key":"88_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc1391","volume":"4","author":"BP Toole","year":"2004","unstructured":"Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4:528\u201339.","journal-title":"Nat Rev Cancer"},{"key":"88_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.colsurfb.2011.10.029","volume":"99","author":"KY Choi","year":"2012","unstructured":"Choi KY, Saravanakumar G, Park JH, Park K. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces. 2012;99:82\u201394.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"88_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1021\/mp2000428","volume":"8","author":"HSS Qhattal","year":"2011","unstructured":"Qhattal HSS, Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm. 2011;8:1233\u201346.","journal-title":"Mol Pharm"},{"key":"88_CR25","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1016\/j.biomaterials.2013.03.059","volume":"34","author":"SW Morton","year":"2013","unstructured":"Morton SW, Poon ZY, Hammond PT. The architecture and biological performance of drug-loaded LbL nanoparticles. Biomaterials. 2013;34:5328\u201335.","journal-title":"Biomaterials"},{"key":"88_CR26","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1021\/nn4047925","volume":"7","author":"ZJ Deng","year":"2013","unstructured":"Deng ZJ, Morton SW, Ben-Akiva E, Dreaden EC, Shopsowitz KE, Hammond PT. Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano. 2013;7:9571\u201384.","journal-title":"ACS Nano"},{"key":"88_CR27","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1039\/C4NR06910B","volume":"19","author":"S Maiolino","year":"2015","unstructured":"Maiolino S, Moret F, Conte C, Fraix A, Tirino P, Ungaro F, et al. Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo\/chemo-therapy of cancer. Nanoscale. 2015;19:5643\u201353.","journal-title":"Nanoscale"},{"key":"88_CR28","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1096\/fj.02-0088com","volume":"16","author":"J Panyam","year":"2002","unstructured":"Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb Journal. 2002;16:1217\u201326.","journal-title":"Faseb Journal"},{"key":"88_CR29","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1016\/j.biomaterials.2013.04.052","volume":"34","author":"X Zeng","year":"2013","unstructured":"Zeng X, Tao W, Mei L, Huang L, Tan C, Feng SS. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials. 2013;34:6058\u201367.","journal-title":"Biomaterials"},{"key":"88_CR30","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1016\/j.biomaterials.2011.02.022","volume":"32","author":"Y Mi","year":"2011","unstructured":"Mi Y, Liu Y, Feng SS. Formulation of Docetaxel by folic acid-conjugated d\u2009\u2212\u2009+\u00a6-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials. 2011;32:4058\u201366.","journal-title":"Biomaterials"},{"key":"88_CR31","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1016\/j.biomaterials.2012.01.036","volume":"33","author":"MS Muthu","year":"2012","unstructured":"Muthu MS, Kulkarni SA, Raju A, Feng SS. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials. 2012;33:3494\u2013501.","journal-title":"Biomaterials"},{"key":"88_CR32","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1166\/jbn.2014.1844","volume":"10","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zeng X, Ma Y, Liu J, Tang X, Gao Y, et al. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer. J Biomed Nanotechnol. 2014;10:1509\u201319.","journal-title":"J Biomed Nanotechnol"},{"key":"88_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bios.2011.10.040","volume":"31","author":"RM Iost","year":"2012","unstructured":"Iost RM, Crespilho FN. Layer-by-layer self-assembly and electrochemistry: applications in biosensing and bioelectronics. Biosens Bioelectron. 2012;31:1\u201310.","journal-title":"Biosens Bioelectron"},{"key":"88_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s11596-013-1192-x","volume":"33","author":"W Shi","year":"2013","unstructured":"Shi W, Zhang ZJ, Yuan Y, Xing EM, Qin Y, Peng ZJ, et al. Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method. J Huazhong Univ Sci Technolog Med Sci. 2013;33:754\u20138.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"88_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijpharm.2014.06.058","volume":"473","author":"G Palma","year":"2014","unstructured":"Palma G, Conte C, Barbieri A, Bimonte S, Luciano A, Rea D, et al. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer. Int J Pharm. 2014;473:55\u201363.","journal-title":"Int J Pharm"},{"key":"88_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/oli.2008.0168","volume":"19","author":"S Taetz","year":"2009","unstructured":"Taetz S, Bochot A, Surace C, Arpicco S, Renoir JM, Schaefer UF, et al. Hyaluronic acid-modified DOTAP\/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Oligonucleotides. 2009;19:103\u201315.","journal-title":"Oligonucleotides"},{"key":"88_CR37","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1021\/bm060300u","volume":"7","author":"NP Gabrielson","year":"2006","unstructured":"Gabrielson NP, Pack DW. Acetylation of polyethylenimine enhances gene delivery via weakened polymer\/DNA interactions. Biomacromolecules. 2006;7:2427\u201335.","journal-title":"Biomacromolecules"},{"key":"88_CR38","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1021\/bm800291v","volume":"9","author":"X Liu","year":"2008","unstructured":"Liu X, Yang JW, Lynn DM. Addition of \u201ccharge-shifting\u201d side chains to linear poly(ethyleneimine) enhances cell transfection efficiency. Biomacromolecules. 2008;9:2063\u201371.","journal-title":"Biomacromolecules"},{"key":"88_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/0955-0674(94)90100-7","volume":"6","author":"L Sherman","year":"1994","unstructured":"Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors - Key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol. 1994;6:726\u201333.","journal-title":"Curr Opin Cell Biol"},{"key":"88_CR40","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.18632\/oncotarget.2591","volume":"5","author":"D Esposito","year":"2014","unstructured":"Esposito D, Crescenzi E, Sagar V, Loreni F, Russo A, Russo G. Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP. Oncotarget. 2014;5:11737\u201351.","journal-title":"Oncotarget"},{"key":"88_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/00003088-199936020-00002","volume":"36","author":"SJ Clarke","year":"1999","unstructured":"Clarke SJ, Rivory LP. Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet. 1999;36:99\u2013114.","journal-title":"Clin Pharmacokinet"},{"key":"88_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10637-009-9266-0","volume":"28","author":"DM Collins","year":"2010","unstructured":"Collins DM, Crown J, O\u2019Donovan N, Devery A, O\u2019Sullivan F, O\u2019Driscoll L, et al. Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. Invest New Drugs. 2010;28:433\u201344.","journal-title":"Invest New Drugs"},{"key":"88_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2014.04.001","volume":"17","author":"A Ganju","year":"2014","unstructured":"Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat. 2014;17:13\u201323.","journal-title":"Drug Resist Updat"},{"key":"88_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0731-7085(02)00571-X","volume":"31","author":"F Ungaro","year":"2003","unstructured":"Ungaro F, De Rosa G, Miro A, Quaglia F. Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations. J Pharm Biomed Anal. 2003;31:143\u20139.","journal-title":"J Pharm Biomed Anal"},{"key":"88_CR45","doi-asserted-by":"publisher","first-page":"e58845","DOI":"10.1371\/journal.pone.0058845","volume":"8","author":"F Fiorito","year":"2013","unstructured":"Fiorito F, Irace C, Di PA, Colonna A, Iovane G, Pagnini U, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes BHV-1 infection in mammalian cells by interfering with iron homeostasis regulation. PLoS One. 2013;8:e58845.","journal-title":"PLoS One"},{"key":"88_CR46","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbagrm.2008.08.006","volume":"1779","author":"A Russo","year":"2008","unstructured":"Russo A, Cirulli C, Amoresano A, Pucci P, Pietropaolo C, Russo G. cis-acting sequences and trans-acting factors in the localization of mRNA for mitochondrial ribosomal proteins. Biochim Biophys Acta. 2008;1779:820\u20139.","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-015-0088-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-015-0088-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-015-0088-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-015-0088-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:12:58Z","timestamp":1630577578000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-015-0088-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,3]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1186\/s12951-015-0088-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,3]]},"assertion":[{"value":"8 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}